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Abstract
Introduction. The incidence of acute pancreatitis (AP) in children has increased signiﬁcantly in the past two decades.
Objective. All cases of AP, acute recurrent pancreatitis (ARP), and chronic pancreatitis examined between May 2002 and
May 2012 at Hospital de Braga, Portugal, were reviewed. Material and methods. Patients were identiﬁed by searching the
hospital’s electronic discharge records for the International Classiﬁcation of Disease, Ninth Revision (ICD-9) code 577.0 (acute
pancreatitis). ARP was considered as two or more episodes of AP per year or more than three episodes over a lifetime with
intervening return to baseline. The following data were analyzed: demographic information, clinical, laboratory and imaging
test results, etiology of pancreatitis, medical and surgical management, length of hospitalization, and outcome. The clinical and
laboratory factors used in the pediatric acute pancreatitis severity score system and computed tomography severity index
(CTSI) score were compared between patients with mild and severe disease. Results. A total of 37 patients, 31 episodes of AP
and 6 patients with ARP, were documented. The most prevalent etiologies were biliary stones/sludge (24.3%) and trauma
(16.2%). Admission elevated white blood cell count (p = 0.011), 48-h trough calcium (p = 0.007), and 48-h rise in blood urea
nitrogen (p = 0.025) correlated signiﬁcantly with disease severity. CTSI on admission had a score below 4 in three patients with
severe disease. Conclusion. This Portuguese pediatric pancreatitis report highlights the multiple and complex etiology of this
disease. Better pediatric scoring systems and management algorithms are needed.
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Introduction
Acute pancreatitis (AP) is a reversible condition char-
acterized by acinar cell injury of the pancreas and a
subsequent inﬂammatory response that may involve
adjacent and distant tissues and organs. The magni-
tude of this inﬂammatory response determines the
severity of AP and can lead to complications such as
pancreatic necrosis, effusions, shock, and multiorgan
system failure. A small number of patients have
recurrent episodes of AP and are at risk of developing
chronic pancreatitis (CP). Fibrosis and chronic
inﬂammation can lead to exocrine failure and in a
later stage endocrine compromise with the develop-
ment of diabetes [1–5].
Pancreatitis in pediatric patients is a costly and
increasingly recognized disease [6–8].
The current incidence seems to be around 3.6–
13.2 cases per 100,000 individuals per year, according
to some studies from Australia and United States
[1,2,7–9]. The reasons for this increase are not
entirely clear and could represent more a geographic
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than a worldwide phenomenon. However, it could
result from greater physician awareness or changing
trends in pancreatitis etiologies [7–11].
There is limited literature on AP, acute recurrent
pancreatitis (ARP), and CP in children, and knowl-
edge is often extrapolated from adult data. The
INSPPIRE (International Study Group of Pediatric
Pancreatitis: In search for a cure) consortium was
formed and since 2012 it represents the ﬁrst initiative
to create a multicenter approach to systematically
characterize pancreatitis in children [12].
Materials and methods
The records of all children and adolescents treated for
pancreatitis at our institution from May 2002 to May
2012 were reviewed. Patients were identiﬁed by
searching the hospital’s electronic discharge records
for the International Classiﬁcation of Disease, Ninth
Revision (ICD-9) code 577.0 (acute pancreatitis).
All diagnoses were manually conﬁrmed by review
of admission histories, laboratory values, and imaging
ﬁndings.
The deﬁnition of AP diagnosis required at least two
of three criteria: abdominal pain, especially in the
epigastric region, serum amylase, or lipase activity
at least three times greater than the upper limit of
normal and imaging ﬁndings compatible with AP
[1,2,12,13]. ARP was considered as two or more
episodes of AP per year or more than three episodes
over a lifetime with intervening return to baseline:
complete resolution of pain (‡1 month pain-free
interval) or complete normalization of pancreatic
enzymes levels along with resolution of pain (can
be shorter interval than 1 month) [1,12]. The
diagnosis of CP was checked in the group of ARP
patients, based on a combination of symptoms
(abdominal pain and/or loss of exocrine function),
imaging studies, and pancreatic noninvasive function
tests (fecal elastase screen test and 72-h fecal fat
collection) [1,12].
The following data were analyzed: demographic
information, clinical, laboratory, and imaging test
results, and etiology of pancreatitis. Additional
variables collected were medical and surgical man-
agement, length of hospitalization, and outcome.
Statistical analysis was performed with unequal
variance t-test and p < 0.05 was considered statistically
signiﬁcant. The severity of the disease was classiﬁed as
mild, moderately severe, and severe according to the
last international revision of the Atlanta classiﬁcation
[13].
The clinical and laboratory factors used in the
pediatric acute pancreatitis severity (PAPS) score
system and computed tomography severity index
(CTSI) score were compared between patients with
mild and severe disease [14–17].
Results
Braga hospital served a total of 128,465 pediatric
patients according to Portuguese census 2001. In
2010, the number of children and adolescents
increased, since the hospital became the reference
hospital of Minho region, serving a total of
257,114 pediatric patients according to Portuguese
census 2011.
There were 37 patients (59.5% female) admitted
for pancreatitis betweenMay 2002 andMay 2012.We
identiﬁed 2–6 cases per year with a uniform distribu-
tion over the years. During this period, there were
31 (83.8%) patients with AP and 6 (16.2%) with
ARP. CP was not diagnosed in this pediatric sample,
since there was resolution of pain and/or decrease of
amylase and lipase levels after a mean follow-up
period of 1 month. Fecal elastase test and 72-h fecal
Table I. Etiology of pancreatitis (n = 37).
Etiology n = 37
AP
n
ARP
n
Biliary disease 10
Gallstones/sludge 8 1
Choledochal cyst (type I) 1
Trauma 6
Blunt abdominal injury 4
Motor vehicle accident 1
Projectile ﬁrearm injury 1
Medication 4
Azathioprine 1
Corticosteroids 1
Estrogen 1
Sodium valproate 1
ERCP 3 3
Infection 2
Hepatitis A 1
Mycoplasma pneumoniae 1
Systemic 2
Systemic lupus erythematosus 1
Ulcerative colitis with sclerosing
cholangitis
1
Surgery 2 2
Metabolic 1
Diabetic ketoacidosis 1
Periampullary obstruction 2
Pancreas divisum 1
Enteric duplication cyst 1
Genetic 1
Heterozygous I507del+IVS8 (5T)
cystic ﬁbrosis
1
Oral refeeding 1 1
Neoplasic 1 1
Solid pseudopapillary neoplasm 1
Idiopathic 2 2
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fat collection were performed in ARP patients, but
loss of exocrine pancreatic function was not found.
Development of diabetes did not occur.
There were two patients with family history of
pancreatitis. Abdominal pain was the most recorded
symptom (97.3%). Speciﬁcally, epigastric pain was
reported in 70.3% and diffusely in 27% of the
patients. Epigastric pain radiating to the back
occurred in 13.5% patients. Vomiting was the
second most frequent symptom reported (45.9%),
followed by fever (10.8%). Jaundice was diagnosed
in 8.1% and a palpable mass was detected in 5.4%
patients. Systemic inﬂammatory response syndrome
with transient (<48 h) organ failure was reported in
2.7%.
In this pediatric sample, 9 (24.3%) patients devel-
oped severe pancreatitis. All of these were moderately
severe cases, according to the last international
revision of the Atlanta classiﬁcation [13], since the
most severe case resolve cardiovascular and renal
dysfunction within 48 h.
The median age at presentation was 15 years
(range, 7–17 years). No signiﬁcant difference in age
was noted between the mild and moderately severe
pancreatitis group of patients (p = 0.137).
The median duration of hospitalization was 6 days
(range, 2–89 days). Patients with moderately severe
pancreatitis had longer hospital stays than those with
mild pancreatitis (mean: 40.4 days vs. 10.5 days;
p = 0.013).
The etiological causes associated with pancreatitis
were diverse (Table I).
Biliary disease (gallstones/sludge) was the most
prevalent etiological cause (24.3%), followed by
trauma (16.2%), and medications (10.8%). We
identiﬁed pancreatitis secondary to endoscopic retro-
grade cholangiopancreatography (ERCP) in 3 (8.1%)
patients. A case of pancreas divisum, a heterozygous
I507del+IVS8 (5T) cystic ﬁbrosis patient [18], and a
solid pseudopapillary neoplasm of pancreas (Figure 1)
were rare etiologies related with ARP.
Idiopathic pancreatitis cases were two, but we need
to say that no genetic screening for PRSS-1,
SPINK-1, CFTR, or CTRC was done. These two
cases did not have more than one episode of pancre-
atitis and are followed in our consultation.
Pancreatic ﬂuid collections (Figure 2) and pseu-
docysts (Figure 3) were the most frequent complica-
tions (Table II). Despite the occurrence of two cases
of systemic complications (pulmonary edema and
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Figure 1. MR (T2): Tumoral cystic mass.
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systemic inﬂammatory response syndrome), no one
died. The patient who developed pulmonary edema
was the case of pancreas divisum, and the other with
transient organ failure was related to a blunt abdom-
inal injury with severe pancreatic dysfunction. Other
etiological cause or disease was not found to be
responsible for the systemic complications.
Unequal variance t-test analysis of laboratory data
was applied to our pediatric population. Using the
cutoff values of the PAPS score system, admission
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Figure 2. MRCP (T2): Fluid pancreatic collections + Wirsung ductal injury.
Figure 3. US: Pseudocyst.
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.
elevated white blood cell count (WBC – mean:
10315 ± 698.6 vs. 17700 ± 2236.6; p = 0.011),
48-h trough calcium (48-h Ca2+ – mean: 9.0 ±
0.2 vs. 8.1 ± 0.2; p = 0.007), and 48-h rise in blood
urea nitrogen (BUN – mean: 0.7 ± 0.3 vs. 3.2 ± 0.9;
p = 0.025) correlated signiﬁcantly with disease severity
(Table III). Admission elevated lactate dehydroge-
nase (LDH) and 48-h trough albumin did not have a
statistically stronger association with severe pancrea-
titis. The admission levels of amylase and lipase did
not have that correlation with children’s morbidity
(Table III).
Trans-abdominal ultrasonography revealed inﬂam-
matory changes of the pancreas in 27 of the 34 patients
evaluated. Ultrasound diagnosed all the patients with
gallstone disease and traumatic etiology. The most
common ﬁndings included pancreatic edema, dilated
pancreatic duct, calciﬁcations, and ﬂuid collections.
Contrast-enhanced CT scans were performed in
22 patients, showing evidence of pancreatitis in all of
them, including 7 patients who had negative results
on ultrasound examinations.
CTSI applied in our study showed a score below
4 in three patients with severe disease. ERCP was
done in six patients and it was responsible for three
cases of AP. Magnetic resonance cholangiopancrea-
tography (MRCP) performed in six patients was used
for the diagnosis and better characterization of type I
choledochal cyst case and evaluation of some com-
plications. This exam was not useful for determining
the real cause of the two idiopathic cases.
Supportive therapy (hydration, analgesia, and
antiemetics) was used in all of the cases. Total
parental nutrition was necessary for 5 (13.5%)
patients (mean duration: 20.5 ± 11.2 days) and
2 (5.7%) patients were fed through enteral tube.
Antibiotic therapy was used in the two patients who
developed systemic complications and in the patient
subjected to surgical removal of solid pseudopapillary
tumor. The two children with pseudocyst and imag-
ing evidence of minimal wall necrosis, along with the
two other with acute necrotic collections, were also
under antibiotics.
Surgical management was necessary in 11 (29.7%)
patients, including 4 with post-traumatic injuries.
Cholecystectomy after conservative therapy was
performed in 5 (13.5%) patients, laparoscopic or
percutaneous pancreatic pseudocysts drainage in
4 (10.8%), and partial pancreatic resection with
debridement in 2 (5.4%) patients.
Conclusion
AP in children is an increasing health problem [7–9].
The results of this pediatric sample show that pan-
creatitis can have multiple and complex etiologies in
children. Among the diverse range of etiologies of
pediatric AP, gallstones and biliary disease seem to
play a greater role than previously thought
[1,2,10,11,19–21]. In this report, it was also the
most common (24.3%) etiological cause. CP was
not diagnosed in this pediatric sample.
Admission elevated WBC (p = 0.011), 48-h trough
calcium (p = 0.007), and 48-h rise in BUN (p = 0.025)
correlated signiﬁcantly with disease severity. We did
not ﬁnd a statistical signiﬁcant correlation between
amylase and lipase admission levels and pancreas
damage.
An abdominal ultrasound examination is a useful
tool for the conﬁrmation of clinically and laboratory
diagnosed pancreatitis [1,2,22,23]. In our study, the
sensitivity of trans-abdominal ultrasonography in
detecting pancreatitis was 79.4%. Our results show
that CT scans are useful for the diagnosis of pancre-
atitis in clinically suggestive patients, when abdominal
ultrasound results are not clear [1,22,23].
Table II. Complications related with moderately severe
pancreatitis.
Complications
Local Acute peripancreatic ﬂuid collection/pseudocyst – 4
Acute necrotic collection – 2
Pancreatic tumor – 1
Systemic Systemic inﬂammatory response syndrome – 1
Pulmonary effusion – 1
Table III. Laboratory parameters (mean values).
PAPS score system Mild pancreatitis Severe pancreatitis p
Admission WBC (/mL) 10315 ± 698.6 17700 ± 2236.6 0.011
Admission LDH (IU/L) 338.3 ± 35.8 482.3 ± 127.9 0.321
48-h trough Ca2+ (mg/dL) 9.0 ± 0.2 8.1 ± 0.2 0.007
48-h increase BUN (mg/dL) (") 0.7 ± 0.3 (") 3.2 ± 0.9 0.025
48-h trough albumin (g/dL) 3.7 ± 0.2 3.2 ± 0.3 0.111
Other lab data
Admission amylase (IU/L) 735.9 ± 174.3 699.4 ± 108.2 0.909
Admission lipase (IU/L) 1277.6 ± 347.4 3117.9 ± 1536.2 0.283
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Some studies also evaluated the utility of CTSI in
children with AP, and concluded that this index was
superior to clinical scoring systems for identifying
children at heightened risk for developing serious
complications (cutoff score of 4+). However, the
ﬁndings are observer-dependent, and not all patients
with severe disease have a CTSI equal to or higher
than four [15]. In our study, three patients with severe
disease have an index score below 4.
Current guidelines for classifying, diagnosing, and
managing AP are frequently based on standards that
are developed and validated in adult patients
[12,13,16,23–25]. Better scoring systems to determi-
nate prognosis and new management algorithms are
urgently needed.
Pediatric patient’s outcomes seem to be better than
adults, but the complications related with this disease
are clinical problems difﬁcult to resolve and respon-
sible for longer hospital stays.
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